[1]
|
Consensus development conference:diagnosis, prophylaxis, and treatment of osteoporosis[J]. Am J Med, 1993, 94(6):646-650. |
[2]
|
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志,2017, 20(5):413-443. |
[3]
|
王翯,胡肇衡,陈玲,等. 口服双膦酸盐用药史对静脉注射唑来膦酸治疗骨质疏松发热不良反应的影响[J]. 北京大学学报(医学版), 2016, 48(4):680-682. |
[4]
|
李华. 唑来膦酸和雷洛昔芬治疗绝经后骨质疏松的疗效和不良反应对比分析[J]. 中国处方药, 2017, 15(5):56-57. |
[5]
|
Papapoulos S, Lippuner K, Roux C, et al. The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis:results from the FREEDOM Extension study[J]. Osteoporos Int, 2015, 26(12):2773-2783. |
[6]
|
Stevens JF, Page JE. Xanthohumol and related prenylflavonoids from hops and beer:to your good health![J]. Phytochemistry, 2004, 65(10):1317-1330. |
[7]
|
Slawińska-Brych A, Król SK, Dmoszyńska-Graniczka M, et al. Xanthohumol inhibits cell cycle progression and proliferation of larynx cancer cells in vitro[J]. Chem Biol Interact, 2015, 240:110-118. |
[8]
|
Zhang B, Wei C, Peng W, et al. Xanthohumol induces generation of reactive oxygen species and triggers apoptosis through inhibition of mitochondrial electron transfer chain complex I[J]. Free Radic Biol Med, 2015, 89(1):486. |
[9]
|
Gerhäuser C. Broad spectrum anti-infective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites[J]. Mol Nutr Food Res, 2005, 49(9):827. |
[10]
|
翟远坤,牛银波,潘亚磊,等. 柚皮苷对体外培养乳鼠颅骨成骨细胞增殖和分化成熟的影响[J]. 中国中药杂志, 2013, 38(1):105-111. |
[11]
|
张乃丹. 基于分子对接策略的熟地黄防治糖尿病性骨质疏松症有效成分及其作用机制研究[D].上海:第二军医大学, 2016. |
[12]
|
Carson JA, Manolagas SC. Effects of sex steroids on bones and muscles:similarities, parallels, and putative interactions in health and disease[J]. Bone, 2015, 80(1):67-78. |
[13]
|
童安莉,陈璐璐,丁桂芝. 成骨细胞骨形成机制研究进展[J]. 中国骨质疏松杂志, 1999(3):63-67. |
[14]
|
Neve A, Corrado A, Cantatore FP. Osteoblast physiology in normal and pathological conditions[J]. Cell Tissue Res, 2011, 343(2):289-302. |